Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Five sessions to save lives: new therapy targets suicidal teens

NCT ID NCT07627243

Symptom relief Sponsor: Tel Aviv University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial tests a short, 5-session therapy called IPT-A-SCI for children and teens aged 8-18 who have suicidal thoughts or behaviors. The therapy combines interpersonal psychotherapy with safety planning. Researchers want to see if it reduces suicidal thoughts and if the effects last three months after treatment ends. About 120 participants will complete questionnaires at several points, and their parents will also fill out surveys.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ultra-brief interpersonal psychotherapy (IPT-A-SCI) combined with safety planning
What this could lead to
If it works, this could provide a quick, effective therapy option to reduce suicidal thoughts and behaviors in young people.
What could go wrong
This is a small, early-stage trial with no control group, so results may not be conclusive. The therapy is very brief, which may not be enough for some participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

8 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children and adolescents aged 8-18 years presenting with suicidal ideation or behavior * Suicide risk assessment indicating suitability for outpatient treatment, * Fluency in Hebrew * Ability to attend five weekly treatment sessions * Written informed consent provided by parents or legal guardians * Written informed assent/consent provided by participants in accordance with age and local ethical regulations Exclusion Criteria: * Acute medical or psychiatric condition requiring immediate inpatient treatment * Linguistic, developmental, neurological, or intellectual limitations that prevent understanding of the treatment protocol or study procedures * Inability to participate in outpatient psychotherapy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Suicidal behavior are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Suicidal Ideation Suicide Prevention

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Suicidal behavior Suicidal ideation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Geha Mental Health Center

    Petah Tikva, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.